加快新药开发--从紧急使用授权中汲取的经验教训

AAPS Open Pub Date : 2024-03-04 DOI:10.1186/s41120-023-00089-2

James Bernstein, Kim Huynh-Ba, Patrick Lynch, Thomas Oliver, Reza Oliyai, Scott W. Roberts, Andrea Schirmer, David Schwinke, Kin Tang, Jessica Ursin

{"title":"加快新药开发--从紧急使用授权中汲取的经验教训","authors":"James Bernstein, Kim Huynh-Ba, Patrick Lynch, Thomas Oliver, Reza Oliyai, Scott W. Roberts, Andrea Schirmer, David Schwinke, Kin Tang, Jessica Ursin","doi":"10.1186/s41120-023-00089-2","DOIUrl":null,"url":null,"abstract":"The American Association of Pharmaceutical Scientists (AAPS) Chemistry, Manufacturing, and Control (CMC) Community hosted a virtual panel discussion on July 15, 2022, to provide a forum to discuss industry and regulator CMC challenges associated with emergency use authorizations.","PeriodicalId":453,"journal":{"name":"AAPS Open","volume":"2012 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-03-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Acceleration of new medicines–CMC lessons learned from emergency use authorizations\",\"authors\":\"James Bernstein, Kim Huynh-Ba, Patrick Lynch, Thomas Oliver, Reza Oliyai, Scott W. Roberts, Andrea Schirmer, David Schwinke, Kin Tang, Jessica Ursin\",\"doi\":\"10.1186/s41120-023-00089-2\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The American Association of Pharmaceutical Scientists (AAPS) Chemistry, Manufacturing, and Control (CMC) Community hosted a virtual panel discussion on July 15, 2022, to provide a forum to discuss industry and regulator CMC challenges associated with emergency use authorizations.\",\"PeriodicalId\":453,\"journal\":{\"name\":\"AAPS Open\",\"volume\":\"2012 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-03-04\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"AAPS Open\",\"FirstCategoryId\":\"1\",\"ListUrlMain\":\"https://doi.org/10.1186/s41120-023-00089-2\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"AAPS Open","FirstCategoryId":"1","ListUrlMain":"https://doi.org/10.1186/s41120-023-00089-2","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

美国制药科学家协会 (AAPS) 化学、制造和控制 (CMC) 社区于 2022 年 7 月 15 日举办了一次虚拟小组讨论会，提供了一个讨论与紧急使用授权相关的行业和监管机构 CMC 挑战的论坛。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Acceleration of new medicines–CMC lessons learned from emergency use authorizations

The American Association of Pharmaceutical Scientists (AAPS) Chemistry, Manufacturing, and Control (CMC) Community hosted a virtual panel discussion on July 15, 2022, to provide a forum to discuss industry and regulator CMC challenges associated with emergency use authorizations.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

AAPS Open

自引率

0.00%

发文量